Skip to main content
. Author manuscript; available in PMC: 2012 Apr 30.
Published in final edited form as: Adv Drug Deliv Rev. 2011 Mar 1;63(4-5):324–330. doi: 10.1016/j.addr.2011.01.013

Figure 2.

Figure 2

Schematic outline of potential therapeutic applications of iPSC. iPSC can be differentiated into cardiomyocytes for drug screening and discovery. Autologous or haplotype matched iPSC-derived cells can be used for myocardial regenerative therapies post myocardial infarction. iPSC can be derived from specific patients to recreate the disease-in-a-dish models in-vitro for study.